Podcast
MSL Talk: Tom Caravela, George Lehman
See One, Be One, Teach One…. How to be a Leader in Your Space
Summary
In this episode, Abi Adenola shares her inspiring journey from pharmacy to becoming an MSL, detailing her experiences in medical information and the MSL role. Abi emphasizes the significance of mentorship in her career, offering insights into how mentorship can be applied daily to foster professional growth. She provides strategies and advice for aspiring MSLs and leaders, highlighting the dual importance of leadership and mentorship in career development. Abi discusses the key skills necessary for success, including networking, persistence, and confidence, and stresses the value of giving back. The episode concludes with a focus on being intentional in career and mentorship efforts, followed by closing remarks and a call to action for listeners.
My guest today is Abi Adenola, Medical Science Liaison at Leo Pharma. We discuss how to be a leader and mentor in your space and the importance of mentorship.
In this episode we discuss:
- Abi’s background
- What made her want to transition to industry and how did she go about it
- “See one, teach one, be one”
- Can this concept be applied to any industry and if so, how?
- How important are mentors in the MSL role?
- Abi’s advice for MSLs and aspiring MSLs on how they can position themselves
Pharmacy to MSL transition, Medical Science Liaison mentorship, career development in MSL role, leadership in pharmaceutical industry, networking for MSLs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, George Lehman
Podcast
MSL Talk: Tom Caravela, Cassie James
From Pharmacy to MSL: How an Rx background can lead to industry
Article
Yan Ji, Jin Y. Jin, David M. Hyman, Geoffrey Kim and Ajit Suri
Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology
Article
Ashley Woolmore , Dirk Arnold , Jean‐Yves Blay , Christian Buske , Alfredo Carrato , Winald Gerritsen , Marc Peeters , Jesus Garcia‐Foncillas , David Kerr
The Oncology Data Network (ODN): Methodology, Challenges, and Achievements
Article
Alyson Haslam, PhD; Vinay Prasad, MD, MPH
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Article
Ali Raza Khaki